Evidence map›Paper›PMID 40379618›Full record

ArticleNature communications2025

SARS-CoV-2 induced immune perturbations in infants vary with disease severity and differ from adults' responses.

Djamel Nehar-Belaid, Asunción Mejías, Zhaohui Xu, Radu Marches, Rushil Yerrabelli, Guo Chen, Sara Mertz, Fang Ye, Pablo J Sánchez, John S Tsang and 8 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Unique nasal cell states induced by common pediatric respiratory viruses.bioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. MX1Journal of translational medicine · 2026
    Article
  5. Review
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Djamel Nehar-Belaid *The Jackson Laboratory for Genomic Medicine, Farmington, CT, 06032, USA.ORCID http://orcid.org/0000-0001-6002-5021
Asunción Mejías *Department of Pediatrics, Nationwide Children's Hospital and The Ohio State University College of Medicine, Columbus, OH, USA.ORCID http://orcid.org/0000-0002-5983-8006
Zhaohui XuCenter for Vaccines and Immunity, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, 43205, USA.ORCID http://orcid.org/0000-0003-0645-1737
Radu MarchesThe Jackson Laboratory for Genomic Medicine, Farmington, CT, 06032, USA.
Rushil YerrabelliThe Jackson Laboratory for Genomic Medicine, Farmington, CT, 06032, USA.
Guo ChenThe Jackson Laboratory for Genomic Medicine, Farmington, CT, 06032, USA.ORCID http://orcid.org/0000-0002-3857-3600
Sara MertzCenter for Vaccines and Immunity, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, 43205, USA.
Fang YeCenter for Vaccines and Immunity, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, 43205, USA.
Pablo J SánchezDepartment of Pediatrics, Division of Neonatology and Center for Perinatal Research, Ohio Perinatal Research Network, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, USA.ORCID http://orcid.org/0000-0003-2437-1247
John S TsangCenter for Systems and Engineering Immunology, Departments of Immunobiology and Biomedical Engineering, Yale University, New Haven, CT, 06520, USA.ORCID http://orcid.org/0000-0003-3186-3047
Teresa AydilloDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, 10029, USA.ORCID http://orcid.org/0000-0003-3086-1058
Lisa MiorinDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, 10029, USA.
Anastasija CupicDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, 10029, USA.
Adolfo García-SastreDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, 10029, USA.ORCID http://orcid.org/0000-0002-6551-1827
Duygu UcarThe Jackson Laboratory for Genomic Medicine, Farmington, CT, 06032, USA.ORCID http://orcid.org/0000-0002-9772-3066
Jacques F BanchereauThe Jackson Laboratory for Genomic Medicine, Farmington, CT, 06032, USA. jacques.banchereau@gmail.com.
Virginia PascualDrukier Institute for Children's Health and Department of Pediatrics, Weill Cornell Medicine, New York, NY, USA. vip2021@med.cornell.edu.ORCID http://orcid.org/0000-0002-8806-8426
Octavio RamiloDepartment of Pediatrics, Nationwide Children's Hospital and The Ohio State University College of Medicine, Columbus, OH, USA. octavio.ramilo@stjude.org.ORCID http://orcid.org/0000-0002-0565-5239

Funding

Shared Resource ManagementP30CA034196 · NCI · JACKSON LABORATORY · PI Paul Robson · 1985 to 2026
$61.9M
Project 2U19AI168632 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Octavio Ramilo · 2022 to 2026
$10.2M
Subjects and Samples CoreP01AI179570 · NIAID · YALE UNIVERSITY · PI Carrie L. Lucas, John S Tsang · 2025 to 2026
$9.1M
High Precision System Analysis of Infant Immune ResponsesU01AI131386 · NIAID · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI RAMILO, OCTAVIO, SANCHEZ, PABLO J · 2017 to 2021
$6.3M
NCI NIH HHS P30 CA034196NIAID NIH HHS P01 AI179570NIAID NIH HHS U19 AI168632U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID) U01AI131386
6 · The paper itself

Abstract

Differences in immune profiles of children and adults with COVID-19 have been previously described. However, no systematic studies have been reported from infants hospitalized with severe disease. We applied a multidimensional approach to decipher the immune responses of SARS-CoV-2 infected infants (n = 26; 10 subacute, 11 moderate and 5 severe disease; median age = 1.6 months) and matched controls (n = 14; median age = 2 months). Single cell (scRNA-seq) profiling of PBMCs revealed substantial alterations in cell composition in SARS-CoV-2 infected infants; with most cell-types switching to an interferon-stimulated gene (ISG

Indexed as

COVID-19SARS-CoV-2AdultAntibodies, ViralAutoantibodiesB-LymphocytesCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCytokinesFemaleHumansInfantInterferonsLeukocytes, MononuclearMaleMonocytesAntibodies, ViralAutoantibodiesCytokinesInterferons

Identifiers

PMID40379618
PMCPMC12084365

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.